Jones C
ORCID: 0000-0002-7288-8235
· 12 papers in corpus
other
2026
INTRODUCTION: Premenstrual symptoms are common physical, psychological, and behavioural symptoms that occur before the onset of menstruation. Despite their cyclical nature, these symptoms can be severe and burdensome, potentially interferin…
qualitative
2026
INTRODUCTION: Quantitative research examining hormonal contraception and its relationship with health, particularly mental health and wellbeing, has been inconclusive with mixed evidence regarding the magnitude and direction of associations…
other
2026
2026
review
2024
Rethinking the application of nanoparticles in women's reproductive health and assisted reproduction
Nanoparticles and nanotechnology may present opportunities to revolutionize the prevention, treatment and diagnosis of a range of reproductive health conditions in women. These technologies are also used to improve outcomes of assisted repr…
nonrandomized-trial
2023
In this pilot study, a human intravenous injection of low-dose endotoxin (lipopolysaccharide, LPS) model was used to test if fibromyalgia is associated with altered immune responses to Toll-like receptor 4 (TLR4) activation. Eight women wit…
review
2022
BACKGROUND: Oocyte activation deficiency (OAD) is attributed to the majority of cases underlying failure of ICSI cycles, the standard treatment for male factor infertility. Oocyte activation encompasses a series of concerted events, trigger…
nonrandomized-trial
2020
PURPOSE: To investigate the impact of a 3-month course of intracortical injections of autologous platelet-rich plasma (PRP) upon ovarian reserve markers versus no intervention in women with low ovarian reserve prior to undergoing assisted r…
2018
Background: We report on a unique audit of seven sonographers self-reporting high visualization rates of normal postmenopausal ovaries in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). This audit was ordered …
review
2018
State-of-the-art applications of nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women's health. In this review, we provide a synopsis of potential ap…
rct
2014
STUDY QUESTION: Is the ongoing pregnancy rate with a new aqueous formulation of subcutaneous progesterone (Prolutex(®)) non-inferior to vaginal progesterone (Endometrin(®)) when used for luteal phase support of in vitro fertilization? SUMM…
lab-animal
2013
BACKGROUND: Fallopian tube secretory epithelial cells (FTSECs) have been implicated as a cell-of-origin for high-grade serous epithelial ovarian cancer. However, there are relatively few in vitro models of this tissue type available for use…